DON'T BUY
The pipelines have been secondary beneficiaries of higher oil prices. Have just started to hold their own. It is more like a utility. They will be more interest rate sensitive. Rates have begun to rise. Yielding 4%. The spread is narrowing. Inflation also makes the dividend not very large. Will probably continue to move sideways.
BUY
The catalyst is the higher volumes from more people with diabetes. Diabetes is expected to rise by 20% by 2050. Lots of room to thrive. Novo Nordisk is first out of the gate and has an oral pill. LLY is not bad either.
WATCH
In a maelstrom of a big investor wanting to remove the CEO and the board. Performance of the company has been dreadful so he agrees. They had pricing power, get lowest costs and best railroad efficiency ratios with a rising dividend. This has not been happening in the last few years. There is no reason for drop in cash flow, higher operating prices, etc because it is in an oligopoly.
PARTIAL SELL
Has been suffering from a short seller report that questioned their alleged revenues for the company. Talks about price to sale ratios and companies trading at 10x sales is rising too fast. This is one of these cases. Revenues and earnings growth is difficult to rise quickly to match the trading price. Given the overhang with short sellers, they should sell half if investors have doubled their money. Can avoid anything bad happening to the stock if you are diligent. A high beta stock so get some profits off the table.
BUY

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Their purchase of DentaQuest is a horizontal acquisition. It does give them more access to the US market. It adds diversification to SLF and strengthens their bottom and top lines. Unlock Premium - Try 5i Free

BUY ON WEAKNESS

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The latest pullback could be a good buying opportunity. The thesis has not changed and the growth prospects are intact. This is probably a broader sell off and not about the specific company. Unlock Premium - Try 5i Free

BUY

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Could buy here if you are okay with the stock moving with the commodity prices. The biggest in Canada. Pays a good dividend. Would recommend a small allocation in the energy space overall. Unlock Premium - Try 5i Free

COMMENT

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The energy rally probably still has some legs to it. A consolidation is not unexpected but it seems oil prices could stabilize around $70 to $80. This could lead to shareholder value being increased through dividends or buybacks. Maintaining proper sector allocation is the best way forward. Unlock Premium - Try 5i Free

premiumPremium content

It's a Monthly Gems opinion which is available only for Stockchase Premium

Curated by Allan Tong since 2019.
99+ opinions with 4.15 rating.

TOP PICK
Despite all the negative headlines, Facebook's fundamentals remain strong. Its price/cash flow stands at 20.6x, half the industry standard and its PE of 25.3x is also far below its peers. Gross, operating and profit margins are also strong beats. For instance, Facebook's profit margin stands at 37.18% vs. Twitter's 8.64%. FB's ROI is 27.42% compared to, say,Visa 's at 16.66%. Snap's performance in these categories is all negative.
premiumPremium content

It's a Monthly Gems opinion which is available only for Stockchase Premium

Curated by Allan Tong since 2019.
99+ opinions with 4.15 rating.

TOP PICK
We've chosen TD from the group, based on the historical pattern of the last one now, will later be first. TD has underperformed its peers so far in 2021. Through the first three calendar quarters, TD has gained 17%, while top dog, National Bank, has run twice as far. Actually, this isn't completely accurate; Bank of Nova Scotia has fared slightly worse than TD, but BNS carries more risk because a substantial part of its business is in Latin America which is not exactly known for growth or dependable performance.
WAIT
They report on Wednesday. Well-run and they usuall put out terrific numbers. Over-anxious traders will bid this up before that report release. Wait for that report before making a move.
BUY
They report Wednesday. Many expect super numbers including him. It's a sainted stock, perfect for trading.
DON'T BUY
They report Wednesday. They'd do a lot better if there was a Covid passport in the U.S. as they do in Europe, where they're ahead in things like this. Travel realities will impact Delta's earnings.
COMMENT
On Monday, if the latest Bond box office numbers are huge, AMC will benefit. It this stock overvalued, but then again, a share price is worth what people will pay for it.
BUY ON WEAKNESS
They report Thursday. He expects amazing results. The banks have had a huge run-up, but are still behind the overall market's PE. If this gets hit week, he will buy more.